Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

DEFECTIVE DRUGS

Defective Drugs
Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page
Parker Waichman Nursing Home Abuse Mobile App

Get our Defective Drugs app for iOS and Android devices.

Your Personal Injury Lawyer - Parker Waichman LLP Android app on Google Play

Just Because a Doctor Prescribes a Drug Doesn’t Mean It’s not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Today, the pharmaceutical industry is producing drugs aimed at just about every ailment known to man, adding years to nearly everyone’s life, if not outright saving them. They also enable us to live a better-quality lifestyle for a much longer period of time.

Regrettably, some of the drugs these companies manufacture can ultimately prove to be defective, as well as dangerous – and even deadly. Sometimes it may take years for the side effects to even emerge – which means that ultimately some drugs on the market may end up doing more harm than good.

Like any other for-profit corporate entity, pharmaceutical companies are motivated, in varying degrees, by profit. Sometimes profits are more important than people. Anyone who reads the newspaper knows this to be a fact. In many a lawsuit, a pharmaceutical company will be charged with having known full well about some harmful side effect tied to its flagship billion-dollar powerhouse drug – in some instances, many years in advance of this fact’s public disclosure. Companies hide clinical evidence that a drug may be defective in order to gain the U.S. Food and Drug Administration (FDA)’s approval, and to not create obstacles to sales.

Prescription drugs with deadly or dangerous side effects are sometimes rushed to market without adequate testing, and often people are injured or die before the FDA can identify these drugs as having dangerous side effects that can far outweigh whatever benefits the marketing group had touted.

When an FDA classification leads to a drug recall and when an injury occurs, a lawsuit is frequently filed; drug recall lawsuits typically fall into a range of categories, including drug injury, product liability or medical malpractice lawsuits against drug companies.

If you or a loved one have been injured as a result of a prescription drug, you may have valuable legal rights. Parker Waichman LLP urges you to contact us by completing the form at right or call us at 1-800-YOURLAWYER (1-800-968-7529).

To view more information involving a specific defective drug, drug recall, or drug lawsuit, please click on one of the links listed below.

If the defective drug you are looking for is not below, please visit our Defective Drugs Archives page for additional articles about defective drug lawsuits that Parker Waichman LLP has defended for our clients.

To view defective drug videos from our attorneys Click Here.

Tags:  

Defective Drugs

Defective Drugs NewsRSS Feed

Canadian Class Action Lawsuit Filed over Delatestryl Testosterone Injection

Jul 28, 2014
The manufacturer of Delatestryl, a testosterone injection, is facing a class action lawsuit filed on behalf of plaintiffs in Canada. The complaint,...

FDA Warns Against Use of Painkillers in Teething Babies

Jul 1, 2014
When a baby is in pain or discomfort from teething, some parents may be inclined to use a painkiller to bring relief. On Thursday, however, the U.S....

Family Sues after Pharmacy Student Dies during Externship

Jun 26, 2014
James Yoo, a 22-year old St. John’s University pharmacy student from Manhattan, died unexpectedly when he came into contact with a very...

FDA Requires Label Updates for Hypertension Drug Olmesartan, Review of Heart Risks in Diabetics Inconclusive

Jun 25, 2014
In a Drug Safety Communication issued Tuesday, the U.S. Food and Drug Administration (FDA) said that upon completing its safety review of the blood...

Generic Version of Heart Drug, Toprol XL, Recalled

Jun 25, 2014
A cardiologist at the renowned Cleveland Clinic has long warned of problems with the generic version of the heart medication, Toprol XL. In the past...

FDA Cites GlaxoSmithKline Flu Vaccine Plant for Quality Violations

Jun 25, 2014
The U.S. Food and Drug Administration (FDA) cited a GlaxoSmithKline plant in Canada that makes the flu vaccine Flulaval for failure to meet quality...

Following FDA Black Box Warning for Antidepressants, Study Finds Increase in Suicide Attempts

Jun 24, 2014
When the U.S. Food and Drug Administration (FDA) warned about the increased risk of suicidal thoughts in young people taking antidepressants , the...

Strengthened FDA Warning About Blood Clot Risk with Testosterone Drugs

Jun 23, 2014
The Food and Drug Administration (FDA) has strengthened required warnings about blood clots in men undergoing testosterone-replacement...

Blue Cross Sues Takeda. Eli Lilly Over Actos Costs

Jun 17, 2014
Blue Cross and Blue Shield of Massachusetts filed subrogation actions last week in the Louisiana multidistrict litigation (MDL) over the bladder...

Drug Reps Can Influence Doctors' Off-label Prescribing

Jun 17, 2014
The direct promotion of off-label drug uses by pharmaceutical sales representatives can influence physicians to prescribe medicines for unapproved...

FDA Unveils Drug Database To The Public

Jun 9, 2014
The U.S. Food and Drug Administration (FDA) is releasing searchable data concerning prescription drugs. The publicly available searchable sets of...

GlaxoSmithKline To Pay $105 Million to Settle Off-Label Suits

Jun 6, 2014
GlaxoSmithKline PLC announced on Wednesday that it would pay $105 million in settlements to resolve allegations from 44 states and the District of...
Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5 VendorsBay Inc